Premature ejaculation is considered the most common male sexual
dysfunction. Premature ejaculation is Considered The Most common male
sexual dysfunction. Although its real prevalence is not well known, due
to the current absence of a universal accepted definition which allows
questioning the inclusion criteria and assessment of many published
studies, the analyses with higher statistical significance report 30%.
Although
real STI Prevalence is not well known, due to the current Absence of a
universal definition Accepted Which Allows Questioning the inclusion
criteria and Assessment of Many published studies, the Higher
Statistical Analyses Significance report with 30%. According to the data
of the first Spanish Demographic Study on Premature Ejaculation
revealed in December 2009, 43% of Spaniards suffers from premature ejaculation
in any moment of his life. According To the data of the first Spanish
Demographic Study on Premature Ejaculation Revealed in December 2009,
43% of Spaniards suffers from premature ejaculation in any moment of His
Life.
Because
of the need to create a universal standard in response to the diversity
of existent definitions, the International Society of Sexual Medicine
(ISSM) has proposed a new definition based on objective criteria.
Because of the Need to create a universal standard in response to the
diversity of existent definitions, the International Society of Sexual
Medicine (ISSM) has proposed a new definition based on Objective
criteria. There are evidences enough that suggest the biogenic origin of
the premature ejaculation, genetically determined and in relation to
the inherited sensitivity of the central serotonine receptors.
There Are evidences enough Suggest that the biogenic origin of the premature ejaculation,
genetically Determined and in relation to the inherited sensitivity of
the central serotonin receptors. So far, there was not any specific
available a drug designed for the treatment of premature ejaculation. So
far, There Was Not Any specific drug available to Design for the
Treatment of premature ejaculation. Therefore, the most common practice
was to prescribe “off label” drugs. Therefore, it WAS the MOST common
practice to prescribe “off label” drugs. The European (EMEA) and Spanish
(AEMPS) medicaments agencies approved the use of dapoxetine, a
short-acting selective serotonin reuptake inhibitor.
The European
(EMEA) and Spanish (Competent Authority) Approved agencies medicaments
the use of dapoxetine, a short-acting selective serotonin reuptake
inhibitor. This is an important advance in the treatment of premature
ejaculation. This is an important advance in the Treatment of premature
ejaculation. This article reviews the main aspects regarding the
definition, epidemiology, etiology, classification and treatment options
of premature ejaculation. This article reviews the main Aspects
regarding the definition, epidemiology, etiology, classification and
Treatment Options of premature ejaculation.
You may be interested in reading Premature Ejaculation Treatment and Stop Premature Ejaculation. If you want read more Premature Ejaculation





